Mail

UK markets closed

FTSE 100
8,433.76
+52.41(+0.63%)
FTSE 250
20,645.38
+114.08(+0.56%)
AIM
789.87
+6.17(+0.79%)
GBP/EUR
1.1622
+0.0011(+0.09%)
GBP/USD
1.2525
+0.0001(+0.01%)
Bitcoin GBP
48,536.16
-1,683.63(-3.35%)

Best savings accounts that offer above inflation rates

How to earn the most interest on your savings

Conduit Pharmaceuticals Inc. (CDT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD

Add to watchlist

2.9700

-0.0700

(-2.30%)

At close: 04:00PM EDT

2.9800

+0.01

(+0.34%)

After hours:

07:30PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	219.27M
Enterprise value	216.03M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	N/A
Price/book (mrq)	N/A
Enterprise value/revenue	N/A
Enterprise value/EBITDA	N/A

Trading information

Stock price history

Beta (5Y monthly)	2.50
52-week change ³	-71.70%
S&P500 52-week change ³	26.27%
52-week high ³	25.0000
52-week low ³	0.9500
50-day moving average ³	3.1573
200-day moving average ³	4.8862

Share statistics

Avg vol (3-month) ³	29.55k
Avg vol (10-day) ³	21.81k
Shares outstanding ⁵	73.83M
Implied shares outstanding ⁶	73.83M
Float ⁸	18.9M
% held by insiders ¹	86.65%
% held by institutions ¹	1.95%
Shares short (30 Apr 2024) ⁴	42.49k
Short ratio (30 Apr 2024) ⁴	1.4
Short % of float (30 Apr 2024) ⁴	N/A
Short % of shares outstanding (30 Apr 2024) ⁴	0.06%
Shares short (prior month 28 Mar 2024) ⁴	55.11k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	0.00%

Management effectiveness

Return on assets (ttm)	-90.99%
Return on equity (ttm)	N/A

Income statement

Revenue (ttm)	N/A
Revenue per share (ttm)	N/A
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	N/A
Net income avi to common (ttm)	-535k
Diluted EPS (ttm)	-0.0900
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	4.23M
Total cash per share (mrq)	0.06
Total debt (mrq)	985k
Total debt/equity (mrq)	N/A
Current ratio (mrq)	3.18
Book value per share (mrq)	-0.01

Cash flow statement

Operating cash flow (ttm)	-7.72M
Levered free cash flow (ttm)	N/A